Option Care Health, Inc.
US ˙ NasdaqGS ˙ US68404L2016

SecurityOPCH / Option Care Health, Inc.
InsiderR Carter Pate
This page shows the track record and history of Pate R Carter insider trades in Option Care Health, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by R Carter Pate in OPCH / Option Care Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-08-20 750 27.1886 750 27.1886 20,391 19 29.5900 1,802 8.83
2023-08-17 1,465 34.3200 1,465 34.3200 50,279
2021-05-10 855 16.7413 855 16.7413 14,314
2016-11-10 20,000 1.3000 20,000 1.3000 26,000
2016-06-17 25,000 2.4963 25,000 2.4963 62,408

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OPCH / Option Care Health, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by R Carter Pate in OPCH / Option Care Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2024-09-03 1,465 32.3691 1,465 32.3691 47,421 76 21.7400 -15,571 -32.84

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OPCH / Option Care Health, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-08-21 2025-08-20 4 Pate R Carter OPCH Common Stock P - Purchase D 27.1886 750 20 41,910
2025-05-19 2025-05-14 4 Pate R Carter OPCH Common Stock A - Award D 5,034 41,160
2024-09-05 2024-09-03 4 Pate R Carter OPCH Common Stock S - Sale D 32.3691 -1,465 -47 36,126
2024-09-05 2024-09-03 4 Pate R Carter OPCH Common Stock G - Gift D -67,342 37,591
2024-05-17 2024-05-15 4 Pate R Carter OPCH Common Stock A - Award D 5,325 104,933
2024-05-10 2024-05-09 4 Pate R Carter OPCH Common Stock G - Gift D -6,504 99,608
2023-08-21 2023-08-17 4 Pate R Carter OPCH Common Stock P - Purchase D 34.3200 1,465 50 106,112
2023-06-07 2023-05-17 4 Pate R Carter OPCH Common Stock A - Award D 9,117 104,647
2022-10-05 2022-10-03 4 Pate R Carter OPCH Common Stock S - Sale D 31.9700 -1,928 -62 95,530
2022-09-02 2022-09-01 4 Pate R Carter OPCH Common Stock S - Sale D 30.6500 -1,923 -59 97,458
2022-08-03 2022-08-01 4 Pate R Carter OPCH Common Stock S - Sale D 33.3700 -1,923 -64 99,381
2022-07-12 2022-07-08 4 Pate R Carter OPCH Common Stock S - Sale D 30.0000 -1,923 -58 101,304
2022-06-03 2022-06-01 4 Pate R Carter OPCH Common Stock, par value $0.0001 S - Sale D 30.5400 -1,923 -59 107,070
2022-06-03 2021-12-21 4 Pate R Carter OPCH Common Stock, par value $0.0001 S - Sale D 27.0000 -5,125 -138 100,095
2022-05-24 2022-05-20 4 Pate R Carter OPCH Common Stock, par value $0.0001 A - Award D 8,898 110,275
2021-05-28 2021-05-26 4 Pate R Carter OPCH Common Stock, par value $0.0001 A - Award D 13,626 101,377
2021-05-12 2021-05-10 4 Pate R Carter OPCH Common Stock, par value $0.0001 P - Purchase D 16.7413 855 14 87,751
2020-06-24 2020-06-22 4 Pate R Carter OPCH Common Stock, par value $0.0001 A - Award D 15,237 86,896
2019-12-11 2019-12-11 4 Pate R Carter BIOS Common Stock, par value $0.0001 A - Award D 61,493 286,636
2019-06-05 2019-06-03 4 Pate R Carter BIOS Cash-Settled Restricted Stock Unit A - Award D 27,363 27,363
2018-05-07 2018-05-03 4 Pate R Carter BIOS Common Stock, $.0001 Par Value A - Award D 62,738 225,143
2017-07-05 2017-06-30 4 Pate R Carter BIOS Common Stock, $.0001 Par Value A - Award D 28,736 162,405
2017-05-04 2017-05-02 4 Pate R Carter BIOS Common Stock, $.0001 Par Value A - Award D 49,669 133,669
2016-11-14 2016-11-10 4 Pate R Carter BIOS Common Stock, $.0001 Par Value P - Purchase D 1.3000 20,000 26 84,000
2016-07-08 2016-07-06 4 Pate R Carter BIOS Common Stock, $.0001 Par Value A - Award D 14,000 64,000
2016-07-06 2016-07-01 4 Pate R Carter BIOS Common Stock, $.0001 Par Value A - Award D 20,000 50,000
2016-06-20 2016-06-17 4 Pate R Carter BIOS Common Stock, $.0001 Par Value P - Purchase D 2.4963 25,000 62 30,000
2016-06-02 2016-05-31 4 Pate R Carter BIOS Phantom Stock M - Exercise D -10,000 0
2016-06-02 2016-05-31 4 Pate R Carter BIOS Common Stock, $.0001 Par Value D - Sale to Issuer D 2.7000 -10,000 -27 5,000
2016-06-02 2016-05-31 4 Pate R Carter BIOS Common Stock, $.0001 Par Value M - Exercise D 10,000 15,000
2015-05-22 2015-05-20 4 Pate R Carter BIOS Phantom Stock A - Award D 10,000 10,000
2015-05-20 3 Pate R Carter BIOS Common Stock, $.0001 Par Value D 10,000
2015-05-20 3 Pate R Carter BIOS Common Stock, $.0001 Par Value D 10,000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)